Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Role of SATB2 Immunohistochemistry in the Diagnosis of Colorectal Cancer

Introduction:Special AT-rich sequence-binding protein 2 (Special AT-rich sequence-binding protein2, SATB2) can be used not only for the...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

FH and 2SC Co-expression: Screening for HLRCC with Skin or Uterine Leiomyomas as Initial Symptoms

Introduction:Hereditary leiomyomatosis and renal cell carcinoma (HLRCC), also known as Reed syndrome, is an aggressive disease with a s...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Clinical Differentiation of FH-Deficient Renal Cell Carcinoma

Introduction:Hereditary fumarate hydratase (FH)-deficient renal cell carcinoma is highly aggressive, has a severe clinical course, poor...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Farewell Tumor: A Self-Narrative of SMARCA4-Deficient Tumors

Introduction:The SMARCA4 protein is encoded by the 19p13 gene and is one of the two mutually exclusive ATPase subunits in the SWI/SNF c...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

New Antibody Release // Brief Overview of NUT Midline Carcinoma

Introduction:Nuclear protein of the testis (NUT) is typically expressed only in the testis. The expression of NUT protein in other site...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Week 39 of “Mai Mai” Pathology Reading Notes | Immunohistochemical Markers for Diagnosing Extraskeletal Bone Tumors and Cartilage Tumors

Introduction:Extraskeletal bone tumors and cartilage tumors share similarities with, but also have differences from, similar tumors occ...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

IHC Technique Guide: Improving Poor Tissue Fixation and Dehydration

Preface:During the slide preparation process, difficulties with paraffin tissue sections are often encountered, mostly due to improper ...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Cancer Talk: The Easily Misdiagnosed Pancreatic Cancer

Introduction:Pancreatic cancer is known as the 'king of cancers,' being a common and highly malignant digestive system tumor, with a mo...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

New Use of Antibodies: Application of GATA3 in the Diagnosis of Malignant Mesothelioma

Introduction:GATA3 is one of the markers commonly used in clinical diagnosis for breast cancer and urothelial carcinoma. In breast tiss...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Immunohistochemical Diagnosis of Renal Epithelial Tumors (Part 4)

Introduction:In the previous installments of the immunohistochemical diagnosis series for renal epithelial tumors, we systematically in...
Continue reading
  • «
  • ‹
  • 12
  • 13
  • 14
  • 15
  • 16
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar